ConductScience.org, home

Gene · 175

AGA: aspartylglucosaminidase

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. AGA: aspartylglucosaminidase. Genes, record 175. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/175

On this page

Gene

Symbol
AGA
HGNC
Name
aspartylglucosaminidase
HGNC
NCBI Gene ID
175
NCBI Gene
HGNC ID
HGNC:318
HGNC
Ensembl
ENSG00000038002
NCBI Gene
Aliases
AGU, ASRG, GA
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P20933N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase3462Ensembl, GeneID, HGNC

Source UniProt

Patents39

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026067851 A2026-04-21252P20933Espacenet
JP 2026021331 A2026-02-1010P20933Espacenet
JP 2026004568 A2026-01-1437999P20933Espacenet
EP 4650780 A22025-11-192370P20933Espacenet
JP 2025147176 A2025-10-06587P20933Espacenet
JP 2025529142 A2025-09-045429P20933Espacenet
WO 2025181336 A12025-09-0487P20933Espacenet
US 12371689 B22025-07-295429P20933Espacenet
JP 2025517970 A2025-06-122370P20933Espacenet
JP 2025062604 A2025-04-146758P20933Espacenet

1 to 10 of 39

See all 39 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants449

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleAGA papersNewest fiscal year
ZIADK060101Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease32025
ZIADK060103Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegeneration32025
P30CA068485Cancer Center Support Grant22025
P30CA071789University of Hawaii Cancer Center CCSG22025
R01DK063158Role of Transglutaminase 2 in Celiac Sprue22025
R01NS098819Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD22025
T32MH014592Psychiatric Epidemiology Training Program22025
KL2TR003981UT Southwestern Center for Translational Medicine12025
P01AG019724Frontotemporal Dementia: Genes, Images, and Emotions12025
P01CA108671Myeloproliferative Neoplasms-Research Consortium12025

1 to 10 of 449Source NIH's project files

See all 449 nih grants

Papers942

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Revisiting Enzyme Replacement Therapy for Aspartylglucosaminuria: Truncated Phosphotransferase Enhances Mannose-6-Phosphorylation and Cellular Uptake of Aspartylglucosaminidase.J Inherit Metab Dis202642676279PubTator, text miningPubMed
Phase-Transformation-Driven Orientation Selection and Anisotropic Properties in Gallium Microfibers.Small202642639720PubTator, text miningPubMed
Biochemical characterization of aspartylglucosaminidase missense variants of unclear significance reveals different degrees of functional impairment.Front Chem202642482697PubTator, text miningPubMed
Analysis of end-stage renal disease mediated by cuproptosis-related genes.Clin Nephrol202642383521PubTator, text miningPubMed
Associations of systemic immune-inflammation index and aggregate index of systemic inflammation with acute gouty arthritis in men: a cross-sectional study.Front Med (Lausanne)202642221133PubTator, text miningPubMed
Clinical Utility of Anti-Gliadin IgG Antibody (AGA IgG) and Characterization of Patients with Suspected Non-Celiac Gluten Sensitivity: Prospective, Observational Study in Japan.Nutrients202642197067PubTator, text miningPubMed
Actionable Genomic Alterations and Survival in Gallbladder Cancer: A Documented Stage- and Treatment-Matched Real-World Global Analysis.Cancers (Basel)202642122248PubTator, text miningPubMed
Sex-specific genetic drivers of memory, executive functioning and language in older adults.Brain202641989867PubTator, text miningPubMed
Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies.Front Pharmacol202641769701PubTator, text miningPubMed
Targeting tRNA-Arg-TCT-4-1 suppresses cancer cell growth and tumorigenesis.bioRxiv202641757043PubTator, text miningPubMed

1 to 10 of 942

See all 942 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/175

GET https://conductscience.org/api/genes/v1/175/patents?page=2